Imugene (Australia) Technical Analysis
| IMU Stock | 0.26 0.01 3.70% |
As of the 16th of February 2026, Imugene retains the Standard Deviation of 4.07, market risk adjusted performance of (1.66), and Risk Adjusted Performance of (0.05). Imugene technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Imugene Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Imugene, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImugeneImugene |
Imugene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Imugene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Imugene.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Imugene on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Imugene or generate 0.0% return on investment in Imugene over 90 days. Imugene is related to or competes with Healthco Healthcare, Oceania Healthcare, Ainsworth Game, Centuria Office, and Strickland Metals. Imugene is entity of Australia. It is traded as Stock on AU exchange. More
Imugene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Imugene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Imugene upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 6.67 |
Imugene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Imugene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Imugene's standard deviation. In reality, there are many statistical measures that can use Imugene historical prices to predict the future Imugene's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (1.67) |
Imugene February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.66) | |||
| Mean Deviation | 3.03 | |||
| Coefficient Of Variation | (1,454) | |||
| Standard Deviation | 4.07 | |||
| Variance | 16.53 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (1.67) | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 6.67 | |||
| Skewness | 0.3605 | |||
| Kurtosis | 0.7312 |
Imugene Backtested Returns
Imugene holds Efficiency (Sharpe) Ratio of -0.0362, which attests that the entity had a -0.0362 % return per unit of risk over the last 3 months. Imugene exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Imugene's Market Risk Adjusted Performance of (1.66), standard deviation of 4.07, and Risk Adjusted Performance of (0.05) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.17, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Imugene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Imugene is expected to be smaller as well. At this point, Imugene has a negative expected return of -0.15%. Please make sure to check out Imugene's maximum drawdown, skewness, accumulation distribution, as well as the relationship between the potential upside and kurtosis , to decide if Imugene performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.26 |
Weak reverse predictability
Imugene has weak reverse predictability. Overlapping area represents the amount of predictability between Imugene time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Imugene price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Imugene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Imugene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Imugene Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Imugene volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Imugene Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Imugene on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Imugene based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Imugene price pattern first instead of the macroeconomic environment surrounding Imugene. By analyzing Imugene's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Imugene's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Imugene specific price patterns or momentum indicators. Please read more on our technical analysis page.
Imugene February 16, 2026 Technical Indicators
Most technical analysis of Imugene help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Imugene from various momentum indicators to cycle indicators. When you analyze Imugene charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.66) | |||
| Mean Deviation | 3.03 | |||
| Coefficient Of Variation | (1,454) | |||
| Standard Deviation | 4.07 | |||
| Variance | 16.53 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.59) | |||
| Treynor Ratio | (1.67) | |||
| Maximum Drawdown | 21.8 | |||
| Value At Risk | (6.06) | |||
| Potential Upside | 6.67 | |||
| Skewness | 0.3605 | |||
| Kurtosis | 0.7312 |
Imugene February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Imugene stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (1.00) | ||
| Rate Of Daily Change | 0.96 | ||
| Day Median Price | 0.26 | ||
| Day Typical Price | 0.26 | ||
| Price Action Indicator | 0.00 | ||
| Market Facilitation Index | 0.01 |
Additional Tools for Imugene Stock Analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.